A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

NCT06888115 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Primary Biliary Cholangitis

Interventions

DRUG: CS0159

Sponsor

Cascade Pharmaceuticals, Inc